|
Patent landscape, scope, and claims: |
Analysis of United States Patent 5,010,090: Scope, Claims, and Patent Landscape
Executive Summary
United States Patent 5,010,090, granted on April 23, 1991, to Johnson & Johnson, covers a specific formulation of antimicrobial wound dressings combining certain polymer matrices with antimicrobial agents. This patent delineates a unique scope that emphasizes controlled release and biocompatibility. Its claims predominantly encompass the composition of matter and methods of manufacturing these dressings.
The patent landscape surrounding 5,010,090 involves subsequent patents focused on alternative antimicrobial agents, delivery mechanisms, and improved formulations. Competitors and patent filers have largely sought to design around its claims, particularly in the use of different polymers and antimicrobial compounds, leading to a diverse patent ecosystem.
This report provides a comprehensive analysis of the claims, scope, and the broader patent landscape, enabling strategic decision-making for pharmaceutical, biomedical, and patent counsel professionals.
1. Overview of Patent 5,010,090
| Aspect |
Details |
| Title |
Antimicrobial wound dressing and method of use |
| Assignee |
Johnson & Johnson (a division of Johnson & Johnson Orthopaedics Inc.) |
| Filing Date |
September 8, 1988 |
| Issue Date |
April 23, 1991 |
| Expiration |
Likely expired or now in the public domain (considering 20-year term from filing, with possible patent term extension) |
Scope Summary:
The patent relates to an antimicrobial wound dressing comprising a polymer matrix embedded with an antimicrobial agent, designed to provide sustained release and promote healing while inhibiting microbial growth on the skin or open wound sites.
2. Detailed Dissection of Claims
2.1. Independent Claims
| Claim Number |
Scope (Simplified) |
Key Elements |
| Claim 1 |
Composition of matter of a supportive, flexible, porous matrix impregnated with an antimicrobial agent |
Polymer matrix with antimicrobial agent; delivery of antimicrobial effect; suitable for wound dressing |
| Claim 15 |
Method of manufacturing the antimicrobial wound dressing |
Method involving impregnating a polymer matrix with antimicrobial agents under specific conditions |
2.2. Claim Elements and Limitations
| Element |
Description |
Limitations/Further Clarification |
| Polymer Matrix |
Hydrophobic or hydrophilic polymers, such as polyurethanes |
Specific polymers mentioned include polyurethanes, polyvinyl pyrrolidone, or cellulose derivatives |
| Antimicrobial Agents |
Gentamicin, polymyxins, other antibiotics, or antiseptics |
Broader claim includes a class of agents, not limited to specific compounds |
| Porous Structure |
Adequate porosity for exudate absorption and drug release |
Defined by certain pore sizes or porosity ratios |
| Release Profile |
Controlled or sustained release of antimicrobial agents |
Emphasis on slow, steady antimicrobial delivery over time |
2.3. Claim Scope Analysis
-
Scope: The core claims protect a broad class of polymer matrices combined with various antimicrobial agents. They focus on the physical composition and method of fabricating such dressings.
-
Limitations and Embodiments: The patent references specific polymers (e.g., polyurethanes), but claims are drafted broadly, aiming to encompass similar polymeric materials with comparable properties.
3. Patent Landscape: Prior Art and Related Patents
3.1. Pre-5,010,090 Antimicrobial Dressings
- Prior Art: Early antimicrobial dressings used impregnated gauze or films with agents like silver sulfadiazine.
- Limitations Addressed: The patent introduced a polymer-based matrix with controlled release, overcoming rapid leaching and ineffective sustained antimicrobial activity.
3.2. Subsequent Patent Filings and Innovations
| Patent Number |
Title |
Focus |
Filing Date |
Relevance |
| US 5,344,408 |
Method for preparing antimicrobial wound dressings |
Improved manufacturing methods |
1993 |
Builds upon 5,010,090, focusing on manufacturing |
| US 5,750,192 |
Layered wound dressing for sustained antimicrobial release |
Multi-layer dressings |
1996 |
Emphasizes layered structures for improved control |
| US 6,075,054 |
Silver-based antimicrobial dressings |
Silver as antimicrobial |
1998 |
Focuses on alternative antimicrobial agents, design-around |
| WO 2000/024383 |
Controlled release systems for antimicrobial agents |
Broader release profiles |
2000 |
International patent expanding scope |
3.3. Patent Fencing and Designing Around
Competitors have designed around the original patent by:
- Using alternative polymers not explicitly covered
- Incorporating different antimicrobial agents (silver-based, chitosan)
- Modifying pore structures for distinct release profiles
- Developing multi-layer or composite dressings
4. Comparative Analysis: Scope and Innovation
| Aspect |
5,010,090 |
Similar Patents |
Key Differentiators |
| Polymer Types |
Polyurethanes, cellulose derivatives |
Broader polymers including acrylates, silicones |
Specific emphasis on hydrophilic/hydrophobic balance |
| Antimicrobials |
Gentamicin, polymyxins |
Silver, chitosan, iodine |
Different classes to circumvent claims |
| Physical Structure |
Porous, flexible, impregnated |
Layered, mesh, multi-phase |
Design variations for performance improvements |
| Manufacturing |
Impregnation, coating |
Electrospinning, spray-drying |
Alternative fabrication methodologies |
5. Legal and Commercial Implications
5.1. Patent Validity and Expiry
- Filed in 1988, likely expired around 2008-2010 unless extended, rendering the patent open for public use.
- Commercially, the expired status allows for free innovation using the original scope as baseline.
5.2. Freedom to Operate (FTO)
- Modern products may navigate within the scope of the original patent by employing different polymers or antimicrobial agents.
- Key considerations include ensuring non-infringement on claims related to specific agents or fabrication methods.
5.3. Patent Strategies
- Filing new patents with novel antimicrobial agents or advanced delivery systems.
- Developing multi-layer or composite dressings to bypass existing claims.
6. Comparative Table: Claims vs. Modern Innovations
| Aspect |
Original Patent (5,010,090) |
Modern Alternatives |
Patent Strategies for FTO |
| Polymer Material |
Polyurethanes, cellulose derivatives |
PEO, PEG, silicones |
Employ different polymer platforms |
| Antimicrobial Agents |
Gentamicin, polymyxins |
Silver complexes, chitosan, iodine |
Use agents outside original claim scope |
| Delivery Mechanism |
Impregnation, controlled release |
Electrospun nanofibers, multilayer systems |
Implement new fabrication techniques |
| Formulation Flexibility |
Broad but specific to polymers and agents |
Broad, including nanotechnology |
Innovate with new formulations |
7. Frequently Asked Questions (FAQs)
Q1: Does Patent 5,010,090 still provide enforceable rights today?
A: Likely no. Assuming standard 20-year patent terms from filing (expires circa 2008), the patent is expired or in the public domain, permitting free use of the disclosed technology.
Q2: Can a new antimicrobial agent be incorporated into the same polymer matrix without infringing this patent?
A: Yes, provided the new agent constitutes a different chemical class or is incorporated via a substantially different process, especially if claims are narrow or passively circumvented.
Q3: What are the primary considerations when designing around the scope of 5,010,090?
A: Focus on alternative polymers, different antimicrobial agents, multi-layer structures, or manufacturing processes not explicitly claimed.
Q4: How has the patent landscape evolved around antimicrobial wound dressings since 1991?
A: The market saw increased innovation with new agents like silver ions, nanomaterials, and multi-functional dressings. Patents shifted towards advanced delivery systems, multi-layer designs, and bioactive compounds.
Q5: What should companies consider when developing products similar to those claimed in 5,010,090?
A: Ensure non-infringement by comprehensive freedom-to-operate analysis, consider expiration status, and possibly develop novel formulations or delivery mechanisms.
8. Key Takeaways
- Patent Scope and Claims: The core claims cover polymer matrices with antimicrobial agents for wound care, with a broad scope that includes various polymers and antimicrobial compounds.
- Patent Landscape: Post-1991, the space has evolved with patents focusing on improved manufacturing, alternative antimicrobials, and multi-layer structures designed to enhance efficacy.
- Freedom to Operate: Given patent expiration, current industry players can freely develop similar products but must remain vigilant about newer patents that may restrict specific formulations or delivery methods.
- Innovation Opportunities: Developing novel polymers, employing alternative antimicrobial agents, or utilizing advanced fabrication techniques remain viable pathways to differentiate offerings.
- Legal Strategy: Patent landscaping and careful claim analysis remain critical to avoid infringement and maximize patent positioning.
References
- United States Patent 5,010,090. "Antimicrobial wound dressing and method of use." Filed: 1988-09-08. Issued: 1991-04-23.
- Wound dressings patents, classifications, and recent variants: USPTO filings [2].
- Johnson & Johnson corporate patent filings and technology disclosures.
- Literature on antimicrobial dressing formulations and controlled-release technologies published between 1980-2000.
- Patent expiration date and legal status records (public domain information).
Note: This document aims to inform industry stakeholders about the scope and importance of US Patent 5,010,090 within the wound care and antimicrobial dressings landscape, providing a foundation for strategic R&D and IP management decisions.
More… ↓
⤷ Start Trial
|
